PFEESA

Documented sources of PFEESA in U.S. drinking water are limited because the occurrence dataset is so small. PFEESA is not a high-volume commercial fluorochemical in its own right; it is most often discussed as a transformation product of larger perfluoroether sulfonate precursors and as a fluorochemical manufacturing-process intermediate. The three Columbia County, NY detections cluster geographically (Hudson, Thomaston, Copake — all within roughly 15 miles of one another), suggesting a shared regional groundwater source rather than three independent industrial releases; the Hudson Valley sits east of the Saint-Gobain / Honeywell PFAS plume centered on Hoosick Falls, NY, and the broader region has documented multi-PFAS groundwater impacts. With only three detections in the entire national UCMR 5 dataset, source attribution should be treated as preliminary — EPA included PFEESA in UCMR 5 precisely to build the occurrence dataset that source-identification work will need.

There is no PFEESA-specific Reference Dose, Health Reference Level, or carcinogen classification from EPA, IARC, or NTP. PFEESA is not included in the 2024 NPDWR Hazard Index mixture (the four short-chain PFAS in that mixture are PFHxS, PFNA, HFPO-DA, and PFBS), and there is no individual MCL. Risk assessment is therefore class-extrapolated from the better-studied perfluoroalkyl sulfonic acids (PFOS, PFHxS, PFBS) and broader PFAS: the perfluorinated carbon-fluorine backbone and sulfonate head group are environmentally persistent and biologically mobile, and the structural family is consistently associated with hepatic, immune, and endocrine effects at sufficient exposure. Human pharmacokinetic data for PFEESA is essentially absent — no defensible serum half-life has been published. The very low measured concentrations (well under 1 ppt) at all three detecting utilities mean that, even under conservative class-extrapolated benchmarks, current exposure levels are low.

PFEESA is removed by the same processes that handle other short-chain perfluoroether acids: granular activated carbon (GAC), anion exchange resin, and high-pressure membranes (reverse osmosis, nanofiltration). The short perfluorinated chain and the sulfonate head group together favor anion exchange and RO over GAC — short-chain PFSAs typically break through GAC earlier than long-chain PFSAs of comparable carbon count, mirroring the operational pattern observed with PFBS. Conventional treatment processes — coagulation, sand filtration, disinfection, UV, and ozonation — do not remove PFEESA. Boiling concentrates rather than removes it. NSF/ANSI 53 and NSF P473 certify point-of-use filters for general PFAS reduction; NSF/ANSI 58 covers RO systems. Because PFEESA is not in the federal NPDWR Hazard Index and is detected at very low concentrations at only three small NY utilities, dedicated treatment for PFEESA is not a practical compliance target; utilities meeting the NPDWR Hazard Index and individual PFOA/PFOS/PFHxS/HFPO-DA/PFNA MCLs with GAC, AIX, or RO will incidentally control PFEESA at the same time.